Corrigendum to: PCSK9 regulates expression of scavenger receptors and ox-LDL uptake in macrophages.

No abstract is available for this paper.

• Publication year

  2021

• Venue

  Cardiovascular Research

• Publication date

  2021-12-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/cvr/cvab354PMID 34904641
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• The relationship between oxLDL, sLOX-1, PCSK9 and carotid intima-media thickness in patients with prediabetes and type 2 diabetes

  2025cites this paper
• Prenatal alcohol exposure induces circular and linear long non-coding RNAs, and protein-coding genes linked to proinflammatory neuroimmune function, promoting nerve injury-induced allodynia following morphine treatment

  2025cites this paper
• Therapeutically targeting type I interferon directly to XCR1+ dendritic cells reveals the role of cDC1s in anti-drug antibodies

  2023cites this paper
• Application of PCSK9 Inhibitor in Carotid Stenosis

  2023cites this paper
• Potential miRNA biomarkers and therapeutic targets for early atherosclerotic lesions

  2023cites this paper
• Lysine demethylase 3A is a positive regulator of cardiac myofibroblast transdifferentiation that increases Smad3 phosphorylation following transforming growth factor beta1 stimulation

  2022cites this paper
• Identifying the anti-inflammatory response to lipid lowering therapy: a position paper from the working group on atherosclerosis and vascular biology of the European Society of Cardiology.

  2018cites this paper